High-resolution imaging of human atherosclerotic carotid plaques with micro 18F-FDG PET scanning exploring plaque vulnerability

Journal of Nuclear Cardiology

Volumn 18, Issue 6, 2011, Pages 1066-1075

  Masteling, Marleen G ^a   Zeebregts, Clark J ^a   Tio, René A ^a   Breek, Jan Cees ^b   Tietge, Uwe J F ^a   De Boer, Jan Freark ^a   Glaudemans, Andor W J M ^a   Dierckx, Rudi A J O ^a   Boersma, Hendrikus H ^a   Slart, Riemer H J A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

Author keywords

Atherosclerosis; carotid artery; FDG; microPET; vulnerable plaque

Indexed keywords

CD68 ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; ASYMPTOMATIC DISEASE; BIOACCUMULATION; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CELL INFILTRATION; CELLULAR DISTRIBUTION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG UPTAKE; EX VIVO STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MENTAL HEALTH; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYMPTOMATOLOGY; TRANSIENT ISCHEMIC ATTACK; TRANSITIONAL BLINDNESS;

AGED; AGED, 80 AND OVER; CAROTID STENOSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84655164356     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-011-9460-2     Document Type: Article

References (40)

1. D Izquierdo-Garcia JR Davies MJ Graves JH Rudd JH Gillard PL Weissberg 2009 Comparison of methods for magnetic resonance-guided [18-F] fluorodeoxyglucose positron emission tomography in human carotid arteries: Reproducibility, partial volume correction, and correlation between methods Stroke 40 86 93
2. S Chaturvedi A Bruno T Feasby R Holloway O Benavente SN Cohen 2005 Carotid endarterectomy-an evidence-based review: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology 65 794 801 (Pubitemid 41362117)
3. BM Wallis de Vries GM van Dam RA Tio JL Hillebrands RH Slart CJ Zeebregts 2008 Current imaging modalities to visualize vulnerability within the atherosclerotic carotid plaque J Vasc Surg 48 1620 1629
4. W Chen GG Bural DA Torigian DJ Rader A Alavi 2009 Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries Eur J Nucl Med Mol Imaging 36 144 151
5. S Jander M Sitzer R Schumann M Schroeter M Siebler H Steinmetz 1998 Inflammation in high-grade carotid stenosis: A possible role for macrophages and T cells in plaque destabilization Stroke 29 1625 1630 (Pubitemid 28365585)
6. KM Fifer S Qadir S Subramanian J Vijayakumar AL Figueroa QA Truong 2011 Positron emission tomography measurement of periodontal (18)f-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation J Am Coll Cardiol 57 971 976
7. M Ogawa S Ishino T Mukai D Asano N Teramoto H Watabe 2004 (18)F-FDG accumulation in atherosclerotic plaques: Immunohistochemical and PET imaging study J Nucl Med 45 1245 1250 (Pubitemid 47611672)
8. JH Rudd EA Warburton TD Fryer HA Jones JC Clark N Antoun 2002 Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography Circulation 105 2708 2711 (Pubitemid 34615139)
9. JH Rudd KS Myers S Bansilal J Machac M Woodward V Fuster 2009 Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: A prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study Circ Cardiovasc Imaging 2 107 115
10. M Tatsumi C Cohade Y Nakamoto RL Wahl 2003 Fluorodeoxyglucose uptake in the aortic wall at PET/CT: Possible finding for active atherosclerosis Radiology 229 831 837 (Pubitemid 37467590)
11. A Tawakol RQ Migrino U Hoffmann S Abbara S Houser H Gewirtz 2005 Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography J Nucl Cardiol 12 294 301 (Pubitemid 40790404)
12. JR Davies JH Rudd TD Fryer MJ Graves JC Clark PJ Kirkpatrick 2005 Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging Stroke 36 2642 2647
13. R Meerwaldt RH Slart GM van Dam GJ Luijckx RA Tio CJ Zeebregts 2010 PET/SPECT imaging: From carotid vulnerability to brain viability Eur J Radiol 74 104 109
14. K Okane M Ibaraki H Toyoshima S Sugawara K Takahashi S Miura 2006 18F-FDG accumulation in atherosclerosis: Use of CT and MR co-registration of thoracic and carotid arteries Eur J Nucl Med Mol Imaging 33 589 594
15. A Rominger T Saam S Wolpers CC Cyran M Schmidt S Foerster 2009 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease J Nucl Med 50 1611 1620
16. N Tahara H Kai S Yamagishi M Mizoguchi H Nakaura M Ishibashi 2007 Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome J Am Coll Cardiol 49 1533 1539 (Pubitemid 46517964)
17. N Tahara H Kai H Nakaura M Mizoguchi M Ishibashi H Kaida 2007 The prevalence of inflammation in carotid atherosclerosis: Analysis with fluorodeoxyglucose-positron emission tomography Eur Heart J 28 2243 2248 (Pubitemid 47428937)
18. YC Tai A Ruangma D Rowland S Siegel DF Newport PL Chow 2005 Performance evaluation of the microPET focus: A third-generation microPET scanner dedicated to animal imaging J Nucl Med 46 455 463 (Pubitemid 43093155)
19. M Graebe SF Pedersen L Borgwardt L Hojgaard H Sillesen A Kjaer 2009 Molecular pathology in vulnerable carotid plaques: Correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET) Eur J Vasc Endovasc Surg 37 714 721
20. Y Sheikine K Akram 2010 FDG-PET imaging of atherosclerosis: Do we know what we see? Atherosclerosis 211 371 380
21. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-53.
22. European Carotid Surgery Trialists' Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351(9113):1379-87.
23. CR Becker T Kleffel A Crispin A Knez J Young UJ Schoepf 2001 Coronary artery calcium measurement: Agreement of multirow detector and electron beam CT AJR Am J Roentgenol 176 1295 1298 (Pubitemid 32323277)
24. K Hamacher HH Coenen G Stocklin 1986 Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution J Nucl Med 27 235 238 (Pubitemid 17024868)
25. WE Hellings G Pasterkamp A Vollebregt CA Seldenrijk JP de Vries E Velema 2007 Intraobserver and interobserver variability and spatial differences in histologic examination of carotid endarterectomy specimens J Vasc Surg 46 1147 1154 (Pubitemid 350267075)
26. JH Rudd J Narula HW Strauss R Virmani J Machac M Klimas 2010 Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: Ready for prime time? J Am Coll Cardiol 55 2527 2535
27. M Graebe SF Pedersen L Hojgaard A Kjaer H Sillesen 2010 18FDG PET and ultrasound echolucency in carotid artery plaques JACC Cardiovasc Imaging 3 289 295
28. JR Davies D Izquierdo-Garcia JH Rudd N Figg HK Richards JL Bird 2010 FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis Int J Cardiovasc Imaging 26 41 48
29. PC Calder G Dimitriadis P Newsholme 2007 Glucose metabolism in lymphoid and inflammatory cells and tissues Curr Opin Clin Nutr Metab Care 10 531 540 (Pubitemid 46934126)
30. BL Kietselaer CP Reutelingsperger GA Heidendal MJ Daemen WH Mess L Hofstra 2004 Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis N Engl J Med 350 1472 1473 (Pubitemid 38420011)
31. MA Font A Fernandez A Carvajal C Gamez L Badimon M Slevin 2009 Imaging of early inflammation in low-to-moderate carotid stenosis by 18-FDG-PET Front Biosci 14 3352 3360
32. A Tawakol RQ Migrino GG Bashian S Bedri D Vermylen RC Cury 2006 In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients J Am Coll Cardiol 48 1818 1824 (Pubitemid 44648622)
33. S Ben-Haim E Kupzov A Tamir O Israel 2004 Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT J Nucl Med 45 1816 1821 (Pubitemid 47618437)
34. MP Dunphy A Freiman SM Larson HW Strauss 2005 Association of vascular 18F-FDG uptake with vascular calcification J Nucl Med 46 1278 1284 (Pubitemid 43733476)
35. RM Kwee RJ van Oostenbrugge L Hofstra GJ Teule JM van Engelshoven WH Mess 2008 Identifying vulnerable carotid plaques by noninvasive imaging Neurology 70 2401 2409
36. I Laitinen P Marjamaki M Haaparanta N Savisto VJ Laine SL Soini 2006 Non-specific binding of [18F]FDG to calcifications in atherosclerotic plaques: Experimental study of mouse and human arteries Eur J Nucl Med Mol Imaging 33 1461 1467 (Pubitemid 44885412)
37. SS Silvera HE Aidi JH Rudd V Mani L Yang M Farkouh 2009 Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries Atherosclerosis 207 139 143
38. G Williams GM Kolodny 2009 Retrospective study of coronary uptake of 18F-fluorodeoxyglucose in association with calcification and coronary artery disease: A preliminary study Nucl Med Commun 30 287 291
39. S Ben-Haim E Kupzov A Tamir A Frenkel O Israel 2006 Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies J Nucl Cardiol 13 791 800 (Pubitemid 44890808)
40. B Paulmier M Duet R Khayat N Pierquet-Ghazzar JP Laissy C Maunoury 2008 Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events J Nucl Cardiol 15 209 217 (Pubitemid 351396317)